Telomere Recombination and the ALT Pathway: A Therapeutic Perspective for Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|41|6466-6471

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.41, 2014-12, pp. : 6466-6471

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic targeting of the p53 pathway in cancer stem cells

By Prabhu Varun V   Allen Joshua E   Hong Bo   Zhang Shengliang   Cheng Hairong   El-Deiry Wafik S  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 12, 2012-12 ,pp. : 1161-1174

Informa Healthcare

Access to resources Recommend Favorite

microRNA Biogenesis Pathway as a Therapeutic Target for Human Disease and Cancer

By  

Current Pharmaceutical Design, Vol. 19, Iss. 4, 2013-02 ,pp. : 745-764

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the NF-ΚB pathway in prostate cancer: a promising therapeutic approach?

By  

Current Drug Targets, Vol. 17, Iss. 3, 2016-03 ,pp. : 311-320

Bentham Science Publishers

Access to resources Recommend Favorite

The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications

By  

Current Cancer Drug Targets, Vol. 8, Iss. 3, 2008-05 ,pp. : 187-198

Bentham Science Publishers

Access to resources Recommend Favorite

The Macrophage Stimulating Protein/Ron Pathway as a Potential Therapeutic Target to Impede Multiple Mechanisms Involved in Breast Cancer Progression

By  

Current Drug Targets, Vol. 11, Iss. 9, 2010-09 ,pp. : 1157-1168

Bentham Science Publishers

Access to resources Recommend Favorite